Compound Summary
Compound Information
Xylometazoline hydrochloride
Compound Name: | Xylometazoline hydrochloride |
Compound CID: | 5282386 |
Synonyms: | Xylometazoline hydrochloride 1218-35-5 Xylometazoline HCl Xylometazoline (hydrochloride) 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride More... |
Iupac Name: | 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride |
InChI: | InChI=1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H |
InChIKey: | YGWFCQYETHJKNX-UHFFFAOYSA-N |
Canonical Smiles: | CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl |
Isomeric Smiles: | CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl |
Molecular Weight: | 280.83 |
Molecular Formula: | C16H25ClN2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Xylometazoline hydrochloride
Molecular Weight: | 280.83 |
Molecular Formula: | C16H25ClN2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 19 |
Complexity: | 302 |
Synonyms
Xylometazoline hydrochloride
| Xylometazoline hydrochloride | Xylometazoline hydrochloride |
|---|---|
Xylometazoline hydrochloride |
1218-35-5 |
Xylometazoline HCl |
Xylometazoline (hydrochloride) |
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride |
MFCD00238707 |
MLS000069695 |
UNII-X5S84033NZ |
1H-Imidazole, 2-4-(1,1-dimethylethyl)-2,6-dimethylphenylmethyl-4,5-dihydro-, hydrochloride (1:1) |
SMR000058526 |
DSSTox_CID_25223 |
DSSTox_RID_80760 |
DSSTox_GSID_45223 |
2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride |
2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride |
X5S84033NZ |
Xylometazoline hydrochloride (USP) |
2-(4-tert-butyl-2,6-dimethylphenyl)methyl-4,5-dihydro-1H-imidazole;hydrochloride |
SR-01000000230 |
NCGC00016101-02 |
CAS-1218-35-5 |
Prestwick_574 |
Opera_ID_1744 |
Neo-Synephrine II (TN) |
SCHEMBL41837 |
MLS001076518 |
SPECTRUM1500614 |
CHEMBL1256400 |
DTXSID3045223 |
REGID_for_CID_5282386 |
HMS1568N07 |
HMS1921K09 |
Pharmakon1600-01500614 |
Xylometazoline Hydrochloride ,(S) |
BCP22148 |
HY-B0475 |
Tox21_110305 |
Tox21_501269 |
CCG-39900 |
NSC757378 |
s2576 |
AKOS015895456 |
Tox21_110305_1 |
AC-8301 |
KS-5144 |
LP01269 |
NSC-757378 |
NCGC00016101-10 |
NCGC00094506-01 |
NCGC00094506-02 |
NCGC00094506-03 |
NCGC00094506-04 |
NCGC00094506-05 |
NCGC00261954-01 |
H812 |
AB0013278 |
EU-0101269 |
FT-0603554 |
SW196748-3 |
D00757 |
X 6000 |
Xylometazoline hydrochloride, analytical standard |
218X355 |
A804796 |
J-004686 |
SR-01000000230-2 |
SR-01000000230-7 |
Q27293585 |
Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard |
Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
Xylometazoline hydrochloride
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 7 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Xylometazoline hydrochloride
Statistics Data
Xylometazoline hydrochloride
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 7 | 1 | 1 |
Statistics Data Visualization
Xylometazoline hydrochloride
